Browse Conditions Browse Medicines

NICE publish guidelines on the assessment and management of thyroid disease

For Hashimoto's thyroiditis, Thyroiditis, Hypothyroidism and Hyperthyroidism

The National Institute for Health and Care Excellence (NICE) have published their guideline on the assessment and management of thyroid disease.

The guideline makes a number of recommendations for patients with thyroid disorders covering:
1.1 Information for people with thyroid disease, their families and carers
1.2 Investigating suspected thyroid dysfunction or thyroid enlargement
1.3 Managing primary hypothyroidism
1.4 Follow-up and monitoring of primary hypothyroidism
1.5 Managing and monitoring subclinical hypothyroidism
1.6 Managing thyrotoxicosis
1.7 Follow-up and monitoring of hyperthyroidism
1.8 Managing and monitoring subclinical hyperthyroidism
1.9 Diagnosing, managing and monitoring thyroid enlargement with normal thyroid function

Thyroid disease: the care you should expect
Thyroid disease affects a small gland in the neck called the thyroid gland. An ‘overactive’ thyroid makes too much thyroid hormone. An ‘underactive’ thyroid does not make enough. The thyroid can also become swollen or enlarged. This is known as a ‘goitre’.

Thyroid conditions are very common. They cause many different symptoms and can be hard to diagnose. Most thyroid conditions improve with treatment, but more than one treatment might be suitable depending on the cause of the problem.

We want this guideline to make a difference to people with thyroid disease by making sure:
  • they have information about thyroid disease, including causes and possible treatments
  • they are offered the right tests, treatment and follow-up for their particular condition
  • when there is more than one suitable treatment, they get the information and support they need to make decisions about the different options
  • they have information about any thyroid medication they are taking

NICE website
Accessed 22/11/19
Links available in External Resources

© NICE [2019]

Thyroid disease: assessment and management. NICE guideline [NG145]. Published date: November 2019
Available from: See Link below. All rights reserved. Subject to Notice of rights
NICE guidance is prepared for the National Health Service in England. All NICE guidance is subject to regular review and may be updated or withdrawn. NICE accepts no responsibility for the use of its content in this product/publication.

The information provided by NICE was accurate at the time this article was issued.

NICE information on thyroid disease

Reporting of suspected adverse reactions

Reporting suspected adverse reactions (side effects) after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals or patients are asked to report any suspected adverse reactions via the Yellow Card Scheme at or search for MHRA Yellow Card in the Google Play or Apple App Store.

Disclaimer: This site is designed to offer information for general educational purposes only. The health information furnished on this site and the interactive responses are not intended to be professional advice and are not intended to replace personal consultation with a qualified physician, pharmacist, or other healthcare professional. We cannot provide individual medical advice. You must always seek the advice of a professional for questions related to a disease, disease symptoms, and appropriate therapeutic treatments.

About Hashimoto's thyroiditis About Thyroiditis About Hypothyroidism About Hyperthyroidism